Novartis pays Isomorphic Labs $37.5 million in collab deal
Novartis is paying Isomorphic Labs $37.5 million upfront to collaborate on small molecule drug discovery.
Stay updated with breaking news from Linical Evolution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novartis is paying Isomorphic Labs $37.5 million upfront to collaborate on small molecule drug discovery.
Heather Stefanski joined NMDP/Be The Match in May, 2021 as vice president, medical services.
The US Food and Drink Administration (FDA) has approved Calliditas Therapeutics' Tarpeyo (budesonide) delayed-release capsules to reduce the loss of kidney function in adults with IgAN.
Bristol Myers Squibb has announced it has acquired Karuna Therapeutics, Inc., for a total equity value of $14 billion or $12.7 billion net of estimated cash.
Decentralized clinical trials (DCTs) are gaining increasing interest as they have the potential to make clinical trial operations quicker, more efficient and more accessible to patients. Check out five DCT organizations that have raised big venture capital investments in the last few years.